HA
HAVN Life Sciences Inc.
HAVLF · OTC
$0.00 +0.00% (+$0.00)
Market Cap $3.56K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9Valuation
-
N/A P/FCF N/A
P/E N/A
EV/FFO N/A
Growth
-
N/A FCF growth N/A
EPS growth N/A
Book val. growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
-
N/A ROA N/A
ROIC N/A
Asset turnover N/A
Debt
-
N/A Debt/Assets N/A
Debt/Equity N/A
Net debt/EBITDA N/A
Stability
19 /100
Unstable Profitable years 0
Beta -0.30x
EPS volatility 26,851.12%
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na HAVLF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Tim Moore
Employees
6
Headquarters
Port Moody